1-4 of 4
Robbert Hoogeboom
Close
Sort by
Journal Articles

The Impact of Pausing Bruton Tyrosine Kinase Inhibitor Therapy and Responsiveness of Vaccination in Blood Cancer Patients: Primary Outcome Result for the Randomised Improve Trial

Piers Patten, Jonathan Cook, Nicholas Peckham, Paul Moss, Neil Phillips, Abhishek Abhishek, Thomas Roberts, Georgina Talbot, Vicki Barber, Anne Francis, Fiona Ashford, Lelia Duley, Robbert Hoogeboom, Brian Willett, Nilima Parry-Jones, Toby A. Eyre, Farooq Ahmad Wandroo, Claire Hutchinson, Duncan James Murray, Gratian Vandici, Nicolas Martinez-Calle, Stephen Jenkins, Helen M Parry
Journal: Blood
Blood (2023) 142 (Supplement 1): 1904.
https://doi.org/10.1182/blood-2023-188725
Published: 2023
Journal Articles

Identification of a Novel Proliferating Cell Fraction in Chronic Lymphocytic Leukaemia with High Expression of IgM and Chemokine Receptors

Daniel Friedman, Antony Long, Piers EM Patten, Robbert Hoogeboom
Journal: Blood
Blood (2021) 138 (Supplement 1): 3711.
https://doi.org/10.1182/blood-2021-153415
Published: 2021
Journal Articles

Identification of a Novel B-CLL Subset Expressing Mutated Stereotyped B-Cell Receptors with Specificity for Yeast Mannan

Robbert Hoogeboom, MSc, Kok P. van Kessel, PhD, Thera A.M. Wormhoudt, Roy J.A. Reinten, Ludo M.E. Evers, Arnon P Kater, MD, PhD, Richard J Bende, PhD, Carel J.M. van Noesel, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 623.
https://doi.org/10.1182/blood.V118.21.623.623
Published: 2011
Journal Articles

MALT lymphoma–derived rheumatoid factors are nonpolyreactive high-affinity antibodies

Robbert Hoogeboom, Richard J. Bende, Carel J. M. van Noesel
Journal: Blood
Blood (2010) 116 (10): 1818–1819.
https://doi.org/10.1182/blood-2010-03-274613
Published: 2010